Vext Science, Inc.
VEXTF
$0.20
$0.014.32%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.16M | 13.73M | 12.67M | 13.41M | 11.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.16M | 13.73M | 12.67M | 13.41M | 11.56M |
| Cost of Revenue | 6.64M | 10.40M | 8.70M | 8.54M | 9.28M |
| Gross Profit | 5.52M | 3.33M | 3.97M | 4.87M | 2.28M |
| SG&A Expenses | 4.11M | 6.72M | 3.04M | 2.89M | 3.03M |
| Depreciation & Amortization | 1.41M | -533.00K | 2.39M | 2.46M | 1.28M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.16M | 16.59M | 14.14M | 13.88M | 13.59M |
| Operating Income | 0.00 | -2.86M | -1.47M | -477.00K | -2.03M |
| Income Before Tax | -643.00K | -9.05M | -2.87M | 264.00K | -3.56M |
| Income Tax Expenses | 249.00K | 1.50M | -243.00K | 1.74M | -223.00K |
| Earnings from Continuing Operations | -892.00K | -10.56M | -2.63M | -1.48M | -3.33M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -892.00K | -10.56M | -2.63M | -1.48M | -3.33M |
| EBIT | 0.00 | -2.86M | -1.47M | -477.00K | -2.03M |
| EBITDA | 3.73M | 895.00K | 2.33M | 3.37M | 1.71M |
| EPS Basic | 0.00 | -0.04 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | -0.04 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 247.68M | 247.68M | 247.62M | 247.58M | 247.49M |
| Average Diluted Shares Outstanding | 247.68M | 247.68M | 247.62M | 247.58M | 247.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |